Mint Tower Capital Management B.V.
Position in TBPH — Theravance Biopharma, Inc.
CIK 1666606
AMSTERDAM, P7
Position in TBPH
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$47,430
New position
Shares Held
2,790
first reported quarter
Ownership
0.005%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#133
of 177 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Mint Tower Capital Management B.V. holds $2,612,514 across 10 Biotechnology names. TBPH ranks #3 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
16,472 | $2,186,328 | |
| 2 | TECH |
BIO-TECHNE Corp
|
5,361 | $378,754 | |
| 3 | TBPH |
Theravance Biopharma, Inc.
This page
|
2,790 | $47,430 | |
| 4 | OSRH |
OSR Health, Inc.
|
82,500 | $2 | |
| 5 | 69,162 | $0 | |||
| 6 | OCS |
Oculis Holding AG
|
5,833 | $0 | |
| 7 | 18,459 | $0 | |||
| 8 | ASBP |
Aspire Biopharma Holdings, Inc.
|
25,000 | $0 |
All Filings in TBPH
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $47,430 | 2,790 | Shares | Sole | 2026-08-18 | |
| No filing history on record for this holder in this stock. | ||||||